NanoSphere

𝐓𝐡𝐞 #1 𝐍𝐚𝐧𝐨𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦: 𝐁𝐫𝐢𝐝𝐠𝐢𝐧𝐠 𝐋𝐚𝐛 𝐭𝐨 𝐌𝐚𝐫𝐤𝐞𝐭. By distilling complex research, industry trends, and regulatory, clinical, and preclinical data into clear, actionable insights, NanoSphere accelerates nanomedicine from bench to bedside—fueling scientists, regulators, startups, and investors to act, build, and scale. We are scientists, providing scientist-validated context and real-world tools for clinical, regulatory, and business impact ( LNPs, RNA, delivery tech, ADCs & personalized medicine) through: 𝐂𝐮𝐫𝐚𝐭𝐞𝐝 𝐂𝐨𝐧𝐭𝐞𝐧𝐭 •Daily Digests: We highlight cutting-edge academic papers, with real-world insights from clinical, regulatory, and industry experts as a part of NanoSphere opinion •Monthly Articles: Our "Back to Basics" series and partner features (like with Nanovation Therapeutics) break down the nucleic acid therapeutics landscape. •Expert Newsletters: Monthly updates on regulatory, industry, business, academia, and clinical trials in nanomedicine. 𝐂𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐡𝐚𝐭 𝐂𝐨𝐮𝐧𝐭 •KOL Interviews: We sit down with key opinion leaders to unpack what it really takes to move nanomedicine from lab to clinic. •Making Conference Learnings Accessible to Everyone 𝐑𝐞𝐚𝐥-𝐓𝐢𝐦𝐞 𝐓𝐨𝐨𝐥𝐬 & 𝐑𝐞𝐬𝐨𝐮𝐫𝐜𝐞𝐬 •NanoSphere GPT: Smart answers, no hallucinations—grounded in verified NanoSphere database. •Live Dashboards: Track clinical trials, regulatory shifts, approved nano drugs, AI companies in the space, and more—all updated in real-time. •Regulatory Insights: A curated map of global nanomedicine authorities and their latest moves. •Scientific Archive: Handpicked studies from 2024 to today. Rooted in Switzerland’s FONGIT innovation ecosystem and present in over 40+ global centers, NanoSphere is the go-to for anyone serious about moving nanomedicine from bench to bedside.